How Long Will I Live With Multiple Myeloma? | Myeloma Expert Answers in a Minute or Less (https://www.myeloma.org/videos/how-long-will-i-live-multiple-myeloma-myeloma-expert-answers-minute-or-less)
How Long Will I Live With Multiple Myeloma? | Myeloma Expert Answers in a Minute or Less
"How long will I live with myeloma?" It's one of the first questions patients and families ask after diagnosis. In this video, myeloma expert Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO, explains what we know about multiple myeloma life expectancy and why survival is improving in under a minute.
Learn what influences multiple myeloma life expectancy, why understanding your disease matters, and how education, supportive care, and treatment access can support better outcomes. This video is designed for multiple myeloma patients, care partners, family members, and anyone seeking trustworthy, easy-to-understand information.
Beth Faiman:
When people hear multiple myeloma, one of the first questions that they ask is, how long will I have to live? Hi, my name is Beth Faiman. I am a nurse practitioner and I am a nurse on the International Myeloma Foundation's Nurse Leadership Board, and I am here to talk to you about life expectancy, in a minute or less.
Now, this is a very difficult discussion to have, life expectancy. While I'm pleased to report that eight to 10 years is an average life expectancy, you might be sitting here saying, "I'm only 50 years old. That's not very long." But we've seen dramatic improvements in survival from the year 2000, where patients only lived two to three years, to now where patients are living a normal lifespan in some considerations. So it's important to talk to your healthcare provider about your disease risk status. Learn all you can about the effective treatments, because we have patients living longer than ever based on better supportive care, better clinical trial designs, and getting access to earlier therapies when they are available.
It's so important for you to educate yourself, so you can advocate for yourself, so you can have better outcomes.
Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO
Cleveland Clinic Taussig Cancer Institute
IMF Nurse Leadership Board Member
Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO, has become an exemplary leader in bringing critical knowledge of cancer nursing to clinical providers — locally, nationally, and internationally. As a founding member of the International Myeloma Foundation Nurse Leadership Board (NLB) and practicing clinician, she demonstrates enthusiasm for continuous learning by conducting innovative research and demonstrates the importance of using and integrating new medical knowledge within nursing practices. In 2023, Faiman was given the NP/PA Educator of Distinction Award in Multiple Myeloma and in 2022, Faiman was named the Top NP in Hematology/Oncology and inducted as an inaugural Fellow of Advanced Practice in Oncology (FAPO) awarded by the Advanced Practitioner Society for Hematology and Oncology (APSHO). Faiman is a Distinguished Fellow in the American Academy of Nursing (FAAN). She is the current Editor-in-Chief of Journal of the Advanced Practitioner in Oncology. She remains an active author, presenter, mentor, and educator on the topics of hematology, oncology and supportive cancer care.
Faiman received her Bachelor of Science in Nursing degree from Ursuline Academy (1996), a Master of Science in Nursing at Kent State University (2002), and a PhD in clinical research from Case Western Reserve University (2014). Faiman is an adult nurse practitioner in the Department of Hematology/Oncology at the Cleveland Clinic in Ohio, and a clinical member of the Case Comprehensive Cancer Center under the Cancer Prevention, Control and Population Research Program. She has edited several books and authored many chapters and papers, including Editor of the 3rd Edition of the Multiple Myeloma Textbook for Nurses (2021), and both Editions of the Blood and Marrow Certification Manual for Nurses (2017, 2023), by ONS publishing. She previously held appointments on the American Board of Internal Medicine and American Society of Hematology.
Tag #AsktheIMF to Ask Your Questions on Social Media!
Facebook: @myeloma (https://www.facebook.com/myeloma) | Instagram: @IMFmyeloma (https://www.instagram.com/imfmyeloma/) | Twitter/X: @IMFmyeloma (https://www.twitter.com/IMFmyeloma)
See all of our social media channels at linktr.ee/myeloma (https://linktr.ee/myeloma)